Literature DB >> 9326264

An extensive repeat structure down-regulates human monoamine oxidase A promoter activity independent of an initiator-like sequence.

Q Zhu1, J C Shih.   

Abstract

The 5' flanking sequence of the human monoamine oxidase A (MAO A) gene consists of an extensive repeat structure. Two 90-bp repeats (I and II) were found in the core promoter (the 0.24-kb PvuII/DraII fragment), each containing two Sp1 binding sites. An additional six repeats were found, five of which (III-VII) were upstream and one (-I) downstream of the core promoter. Using transient transfection assay with a human growth hormone reporter gene, we found that the upstream repeating units III-VII (in a 0.78-kb BamHI/DraII fragment) down-regulate core promoter activity to 13 +/- 10% in a human glioma cell line (1242 MG) and 2 +/- 1% in a cervical carcinoma cell line (HeLa), respectively. The 0.24-kb core promoter activity was taken as 100%. Addition of the initiator (Inr)-like sequence to this 0.78-kb fragment (0.82-kb BamHI/-17 fragment) still showed decreased promoter activity (10 +/- 9% in 1242 MG cells and 8 +/- 1% in HeLa cells). Thus, the upstream sequence down-regulates promoter activity with or without the Inr-like sequence. When the Inr-like sequence was added to the core promoter (0.28-kb PvuII/-17 fragment), the promoter activity decreases significantly in both 1242 MG (55 +/- 6%) and HeLa (60 +/- 10%) cells. These results suggest that although the Inr-like sequence is present in the human MAO A promoter, it acts as a negative cis element instead of a transcription initiator.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9326264     DOI: 10.1046/j.1471-4159.1997.69041368.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

Review 1.  Monoamine oxidase in neuropsychiatry and behavior.

Authors:  J C Shih; R F Thompson
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

2.  Monoallelic expression of MAO-A in skin fibroblasts.

Authors:  N Nordquist; L Oreland
Journal:  J Neural Transm (Vienna)       Date:  2007-04-04       Impact factor: 3.575

Review 3.  Transcriptional regulation and multiple functions of MAO genes.

Authors:  Jean C Shih; Jason Boyang Wu; Kevin Chen
Journal:  J Neural Transm (Vienna)       Date:  2011-02-27       Impact factor: 3.575

Review 4.  Monoamine oxidase: from genes to behavior.

Authors:  J C Shih; K Chen; M J Ridd
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

5.  The VNTR 2 repeat in MAOA and delinquent behavior in adolescence and young adulthood: associations and MAOA promoter activity.

Authors:  Guang Guo; Xiao-Ming Ou; Michael Roettger; Jean C Shih
Journal:  Eur J Hum Genet       Date:  2008-01-23       Impact factor: 4.246

Review 6.  Monoamine oxidases: from tissue homogenates to transgenic mice.

Authors:  Jean Chen Shih
Journal:  Neurochem Res       Date:  2007-06-06       Impact factor: 3.996

Review 7.  Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy.

Authors:  Jean C Shih
Journal:  J Neural Transm (Vienna)       Date:  2018-09-27       Impact factor: 3.575

Review 8.  Dopamine and glucose, obesity, and reward deficiency syndrome.

Authors:  Kenneth Blum; Panayotis K Thanos; Mark S Gold
Journal:  Front Psychol       Date:  2014-09-17

Review 9.  Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric.

Authors:  Kenneth Blum; Marcelo Febo; Thomas McLaughlin; Frans J Cronjé; David Han; S Mark Gold
Journal:  J Behav Addict       Date:  2014-08-26       Impact factor: 6.756

10.  Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS).

Authors:  Kenneth Blum; Marlene Oscar-Berman; Zsolt Demetrovics; Debmalya Barh; Mark S Gold
Journal:  Mol Neurobiol       Date:  2014-05-31       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.